IKENA ONCOLOGY INC shareholders Q3 2023

IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 59 filers reported holding IKENA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

IKENA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,249,123$9,738,7038.94%
CHI Advisors LLC 2,180,934$9,443,4453.74%
Atlas Venture Life Science Advisors, LLC 5,018,178$21,728,7113.36%
ACUTA CAPITAL PARTNERS, LLC 551,010$2,385,8731.60%
Vida Ventures Advisors, LLC 225,192$975,0811.51%
BVF INC/IL 3,169,164$13,722,4800.37%
Artal Group S.A. 1,849,513$8,0080.34%
Orbimed Advisors 3,186,166$13,796,0990.29%
OUP Management Co., LLC 26,833$116,1870.26%
Avoro Capital Advisors LLC 1,640,000$7,101,2000.11%
Verition Fund Management LLC 1,721,689$7,454,9130.09%
NEA Management Company, LLC 181,473$707,2000.06%
Sofinnova Investments, Inc. 115,712$501,0330.03%
CORNERCAP INVESTMENT COUNSEL INC 37,244$161,2670.03%
Laurion Capital Management LP 534,657$2,315,0650.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 114,650$496,4350.01%
Virtu Financial LLC 11,675$510.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 407,900$1,766,2070.00%
FMR LLC 4,458,134$19,303,7210.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 57,246$247,8750.00%
External links

This page lists IKENA ONCOLOGY INC's shareholders in Q3 2023. To view IKENA ONCOLOGY INC's shareholder history, click here.